» Articles » PMID: 6306441

A Review of Animal Phosphofructokinase Isozymes with an Emphasis on Their Physiological Role

Overview
Publisher Springer
Specialty Biochemistry
Date 1983 Jan 1
PMID 6306441
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Phosphofructokinase (PFK) isozymes and their physiological significance have been the focus of extensive research. The majority of this work has been centered around the PFK isozymes of rat, human and rabbit tissues. Consequently, this review emphasizes these studies. Additionally, a review of PFK isozymes in chickens, mice, guinea pig, and pig is presented. The relationship of the properties of each PFK isozyme in different tissues to the rates of glycolysis and/or gluconeogenesis in those tissues is discussed where possible. Moreover, the contribution of the different PFK isoenzymes to alterations of the glycolytic rate in various tissues is discussed in relationship to variations in nutritional, hormonal, developmental or pathological status of the animal.

Citing Articles

Context-dependent modification of PFKFB3 in hematopoietic stem cells promotes anaerobic glycolysis and ensures stress hematopoiesis.

Watanuki S, Kobayashi H, Sugiura Y, Yamamoto M, Karigane D, Shiroshita K Elife. 2024; 12.

PMID: 38573813 PMC: 10994660. DOI: 10.7554/eLife.87674.


Genome-wide identification of the gene family and their expression analysis in .

Kim T, Lim H, Denison M, Natarajan S, Oh C Front Genet. 2023; 14:1289557.

PMID: 38028631 PMC: 10665885. DOI: 10.3389/fgene.2023.1289557.


Cancer-associated somatic mutations in human phosphofructokinase-1 reveal a critical electrostatic interaction for allosteric regulation of enzyme activity.

Voronkova M, Hansen H, Cooper M, Miller J, Sukumar N, Geldenhuys W Biochem J. 2023; 480(17):1411-1427.

PMID: 37622331 PMC: 10586780. DOI: 10.1042/BCJ20230207.


Phosphofructokinase Platelet Overexpression Accelerated Colorectal Cancer Cell Growth and Motility.

Lu T, Yang Y, Cheng C, Tu Y, Chen Y, Lee M J Cancer. 2023; 14(6):943-951.

PMID: 37151384 PMC: 10158518. DOI: 10.7150/jca.82738.


Identification of metabolic pathways underlying FGF1 and CHIR99021-mediated cardioprotection.

Xu B, Li F, Zhang W, Su Y, Tang L, Li P iScience. 2022; 25(6):104447.

PMID: 35707727 PMC: 9189130. DOI: 10.1016/j.isci.2022.104447.


References
1.
Clark M, Patten G . Epinephrine activation of phosphofructokinase in perfused rat heart independent of changes in effector concentrations. J Biol Chem. 1981; 256(1):27-30. View

2.
Pilkis S, El-Maghrabi M, Pilkis J, Claus T . Inhibition of fructose-1,6-bisphosphatase by fructose 2,6-bisphosphate. J Biol Chem. 1981; 256(8):3619-22. View

3.
Van Schaftingen E, Hue L, HERS H . Fructose 2,6-bisphosphate, the probably structure of the glucose- and glucagon-sensitive stimulator of phosphofructokinase. Biochem J. 1980; 192(3):897-901. PMC: 1162415. DOI: 10.1042/bj1920897. View

4.
THRASHER J, Cooper M, Dunaway G . Developmental changes in heart and muscle phosphofructokinase isozymes. J Biol Chem. 1981; 256(15):7844-8. View

5.
Tarui S, Okuno G, Ikura Y, Tanaka T, Suda M, Nishikawa M . PHOSPHOFRUCTOKINASE DEFICIENCY IN SKELETAL MUSCLE. A NEW TYPE OF GLYCOGENOSIS. Biochem Biophys Res Commun. 1965; 19:517-23. DOI: 10.1016/0006-291x(65)90156-7. View